Bimekizumab-bkzx

Clin Ther. 2024 Apr;46(4):379-380. doi: 10.1016/j.clinthera.2024.03.009. Epub 2024 May 4.

Author

Miodrag M Mitrić¹

Affiliation

¹ Clinical Therapeutics Science Editor, Elsevier, STMJ, Health and Medical Sciences, Radarweg 29, 1043 NX Amsterdam, The Netherlands. Electronic address: [email protected].

PMID: 38705824
DOI: 10.1016/j.clinthera.2024.03.009

No abstract available

Publication types

Editorial

MeSH terms

Antibodies, Monoclonal, Humanized* / adverse effects
Humans
Psoriasis / drug therapy

Substances

Antibodies, Monoclonal, Humanized